July 6, 2015Open Access

Barriers and facilitators to starting insulin in patients with type 2 diabetes: a systematic review

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

Major barriers to insulin initiation persist despite availability of newer and safer insulin. Healthcare professionals should explore and address these barriers. Targeted interventions should be developed to overcome these barriers.

Leer artículo completoexternamente

Preguntar a la IA

Me gusta

Guardar

Ver artículo completo

Cite This Study

Ng et al. (Mon,) studied this question.

synapsesocial.com/papers/69da23ee0f32475823a3d18b https://doi.org/https://doi.org/10.1111/ijcp.12691

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1A qualitative study on healthcare professionals’ perceived barriers to insulin initiation in a multi-ethnic population2012 · 71 citations
2The role of patient, physician and systemic factors in the management of type 2 diabetes mellitus2002 · 195 citations
3NIDDM Patients' Fears and Hopes About Insulin Therapy: The basis of patient reluctance1997 · 273 citations
4Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)1998 · 20,076 citations
5Experiences of patients with type 2 diabetes starting insulin therapy2007 · 27 citations

Preguntar a la IA

Me gusta

Guardar

Ver artículo completo